Fei Han
AbbVie (United States)(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, DNA Repair Mechanisms, Epigenetics and DNA Methylation, Ferroptosis and cancer prognosis, Genetic factors in colorectal cancer
Most-Cited Works
- → Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis In Vivo(2023)45 cited
- → Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis(2022)31 cited
- → MAIT cell activation and recruitment in inflammation and tissue damage in acute appendicitis(2024)16 cited
- → MAIT cell homing in intestinal homeostasis and inflammation(2025)12 cited
- → Abstract A002: Understanding mechanisms of resistance to WRN small molecule inhibitors(2024)1 cited
- → Restoration of MAIT cell function in healthcare-associated bacterial infections supports recovery of carbapenem efficacy against resistant bacteria(2025)
- → Abstract B017: Loss of UXS1 selectively kills KEAP1 mutant cancer cell lines by depleting pyrimidines and inducing replication stress(2024)
- → From in vivo disposition to therapeutic action: Tracing the pharmacokinetic journey and unveiling the anti-UC potential of oridonin and its sulfonate-conjugate(2025)
- → Microsatellite Instable Cancer Cells Acquire On-target Resistance Mutations to WRN Helicase Inhibitors(2026)